Actigraphic investigation of circadian rhythm functioning and activity levels in children with mucopolysaccharidosis type III (Sanfilippo syndrome)

Journal of Neurodevelopmental Disorders

Volumn 7, Issue 1, 2015, Pages

  Mumford, Rachel A ^a   Mahon, Louise V ^b   Jones, Simon ^d   Bigger, Brian ^e   Canal, Maria ^f   Hare, Dougal Julian ^c  

^a ALDER HEY CHILDREN S HOSPITAL   (United Kingdom)

^b GREATER MANCHESTER MENTAL HEALTH NHS FOUNDATION TRUST   (United Kingdom)

^c CARDIFF UNIVERSITY   (United Kingdom)

^d St Mary's Hospital   (United Kingdom)

^e UNIVERSITY OF MANCHESTER   (United Kingdom)

^f UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Actigraphy; Circadian rhythms; Mucopolysaccharidosis type III; Sanfilippo; Sleep

Indexed keywords

ACTIMETRY; ADOLESCENT; AGE; ARTICLE; CHILD; CHILDHOOD DISEASE; CIRCADIAN RHYTHM; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DESCRIPTIVE RESEARCH; FEMALE; HUMAN; MALE; PERIODICITY; PRESCHOOL CHILD; PRIORITY JOURNAL; SANFILIPPO SYNDROME; SCHOOL CHILD; SLEEP WAKING CYCLE; WAKEFULNESS;

EID: 84941773989     PISSN: 18661947     EISSN: 18661955     Source Type: Journal    
DOI: 10.1186/s11689-015-9126-5     Document Type: Article

References (57)

1. Quine L. Sleep problems in primary school children: comparison between mainstream and special school children. Child Care Health Dev. 2001;27(3):201-21.
2. Krakowiak P, Goodlin-Jones B, Hertz-Picciotto I, Croen LA, Hansen RL. Sleep problems in children with autistic spectrum disorders, developmental delays, and typical development: a population-based study. J Sleep Res. 2008;17(2):197-206.
3. Didden R, Korzilius H, van Aperlo B, van Overloop C, de Vries M. Sleep problems and daytime problem behaviours in children with intellectual disability. J Intellect Disabil Res. 2002;46(7):537-47.
4. Jan JE, Freeman RD. Melatonin therapy for circadian rhythm sleep disorders in children with multiple disabilities: what have we learned in the last decade? Dev Med Child Neurol 2004. 2004;46(11):776-82.
5. Cotton SM, Richdale AL. Sleep patterns and behaviour in typically developing children and children with autism, Down syndrome, Prader-Willi syndrome and intellectual disability. Res Autism Spect Disord. 2010;4(3):490-500.
6. Robinson AM, Richdale AL. Sleep problems in children with an intellectual disability: parental perceptions of sleep problems, and views of treatment effectiveness. Child Care Health Dev. 2004;30(2):139-50.
7. Jan JE, Owens JA, Weiss MD, Johnson KP, Wasdell MB, Freeman RD, et al. Sleep hygiene for children with neurodevelopmental disorders. Pediatrics. 2008;122(6):1343-50.
8. Sadeh A. Consequences of sleep loss or sleep disruption in children. Sleep Med Clin. 2007;2(3):513-20.
9. Chu J, Richdale AL. Sleep quality and psychological wellbeing in mothers of children with developmental disabilities. Res Dev Disabil. 2009;30(6):1512-22.
10. Doo S, Wing YK. Sleep problems of children with pervasive developmental disorders: correlation with parental stress. Dev Med Child Neurol. 2006;48(8):650-5.
11. Richdale AL, Wiggs L. Behavioral approaches to the treatment of sleep problems in children with developmental disorders: what is the state of the art? Int J Behav Consult Ther. 2005;1(3):165-90.
12. Tietze A-L, Blankenburg M, Hechler T, Michel E, Koh M, Schlüter B, et al. Sleep disturbance in children with multiple disabilities. Sleep Med Rev. 2012;16(2):117-27.
13. Glickman G. Circadian rhythms and sleep in children with autism. Neurosci Biobehav Rev. 2010;34(5):755-68.
14. Hare DJ, Jones S, Evershed K. A comparative study of circadian rhythm functioning and sleep in people with Asperger syndrome. Autism. 2006;10(6):565-75.
15. Hare DJ, Jones S, Evershed K. Objective investigation of the sleep-wake cycle in adults with intellectual disabilities and autistic spectrum disorders. J Intellect Disabil Res. 2006;50(10):701-10.
16. Wiggs L, Stores G. Sleep patterns and sleep disorders in children with autistic spectrum disorders: insights using parent report and actigraphy. Dev Med Child Neurol. 2004;46(6):372-80.
17. De Leersnyder H, Claustrat B, Munnich A, Verloes A. Circadian rhythm disorder in a rare disease: Smith Magenis syndrome. Mol Cell Endocrinol. 2006;252(1-2):88-91.
18. Nomura Y. Early behavior characteristics and sleep disturbance in Rett syndrome. Brain Dev. 2005;27(Suppl1):35-42.
19. Takaesu Y, Komada Y, Inoue Y. Melatonin profile and its relation to circadian rhythm sleep disorders in Angelman syndrome patients. Sleep Med. 2012;13(9):1164-70.
20. Melke J, Goubran Botros H, Chaste P, Betancur C, Nygren G, Anckarsäter H, et al. Abnormal melatonin synthesis in autism spectrum disorders. Mol Psychiatry. 2008;13(1):90-8.
21. De Leersnyder H, de Blois MC, Claustrat B, Romana S, Albrecht U, Von Kleist-Retzow JC, et al. Inversion of the circadian rhythm of melatonin in the Smith-Magenis syndrome. J Pediatr. 2001;139(1):111-6.
22. Gringas P, Gamble C, Jones AP, Wiggs L, Williamson PR, Sutcliffe A, et al. Melatonin for sleep problems in children with neurodevelopmental disorders: randomised double masked placebo controlled trial. BMJ. 2012;345:e6664.
23. Sajith SG, Clarke D. Melatonin and sleep disorders associated with intellectual disability: a clinical review. J Intellect Disabil Res. 2007;51(1):2-13.
24. Cleary MA, Wraith JE. Management of mucopolysaccharidosis type-III. Arch Dis Child. 1993;69(3):403-6.
25. Muenzer J. The mucopolysaccharidoses: a heterogeneous group of disorders with variable pediatric presentations. J Pediatr. 2004;144(Suppl5):27-34.
26. Valstar MJ, Ruijter GJG, van Diggelen OP, Poorthuis BJ, Wijburg FA. Sanfilippo syndrome: a mini review. J Inherit Metab Dis. 2008;31(2):240-52.
27. de Ruijter J, Valstar MJ, Wijburg FA. Mucopolysaccharidosis type III (Sanfilippo syndrome): emerging treatment strategies. Curr Pharm Biotechnol. 2011;12(6):923-30.
28. Bax MCO, Colville GA. Behaviour in mucopolysaccharide disorders. Arch Dis Child. 1995;73(1):77-81.
29. Colville GA, Watters JP, Yule W, Bax MCO. Sleep problems in children with Sanfilippo syndrome. Dev Med Child Neurol. 1996;38(6):538-44.
30. Ruijter GJG, Valstar MJ, van de Kamp JM, van der Helm RM, Durand S, van Diggelen OP, et al. Clinical and genetic spectrum of Sanfilippo type C (MPS IIIC) disease in the Netherlands. Mol Genet Metab. 2008;93(2):104-11.
31. Fraser J, Gason AA, Wraith JE, Delatycki MB. Sleep disturbance in Sanfilippo syndrome: a parental questionnaire study. Arch Dis Child. 2005;90(12):1239-42.
32. Cross EM, Grant S, Jones S, Bigger B, Wraith JE, Hare DJ. Behaviour and development in MPS III, Sanfilippo Syndrome. J Neurodev Disorders. 2015;6:46. doi: 10.1186/1866-1955-6-46.
33. Mahon LV, Lomax M, Grant S, Cross E, Hare DJ, Wraith JE, et al. Assessment of sleep in children with mucopolysaccharidosis type III. PLOS-One. 2014;9(2):1-7.
34. Fraser J, Wraith JE, Delatycki MB. Sleep disturbance in mucopolysaccharidosis type III (Sanfilippo syndrome): a survey of managing clinicians. Clin Genet. 2002;62(5):418-21.
35. Mariotti P, Della Marca G, Iuvone L, Vernacotola S, Ricci R, Mennuni GF, et al. Sleep disorders in Sanfilippo syndrome: a polygraphic study. Clin Electroencephalogr. 2003;34(1):18-22.
36. Guerrero JM, Pozo D, Diaz-Rodriguez JL, Martinez-Cruz F, Vela-Campos F. Impairment of the melatonin rhythm in children with Sanfilippo syndrome. J Pineal Res. 2006;40(2):192-3.
37. Heldermon CD, Hennig AK, Ohlemiller KK, Ogilvie JM, Herzog ED, Breidenbach A, et al. Development of sensory, motor and behavioral deficits in the murine model of Sanfilippo syndrome type. PLoS One. 2007;2(8):e772.
38. Canal MM, Wilkinson FL, Cooper JD, Wraith JE, Wynn R, Bigger BW. Circadian rhythm and suprachiasmatic nucleus alterations in the mouse model of mucopolysaccharidosis IIIB. Behav Brain Res. 2010;209(2):212-20.
39. Grant S, Cross E, Wraith JE, Jones S, Mahon L, Lomax M, et al. Parental social support, coping strategies, resilience factors, stress, anxiety and depression levels in parents of children with MPS III (Sanfilippo syndrome) or children with intellectual disabilities (ID). J Inherit Metab Dis. 2013;36(2):281-91.
40. Ucar SK, Ozbaran B, Demiral N, Yuncu Z, Erermis S, Coker M. Clinical overview of children with mucopolysaccharidosis type III A and effect of risperidone treatment on children and their mothers psychological status. Brain Dev. 2010;32(2):156-61.
41. Samel A, Wegmann HM, Vejvoda M, Maass H, Gundel A, Schutz M. Influence of melatonin treatment on human circadian rhythmicity before and after a simulated 9-hr time shift. J Biol Rhythms. 1991;6(3):235-48.
42. Jean-Louis G, Kripke DF, Mason WJ, Elliot JA, Youndstedt SD. Sleep estimation from wrist movement quantified by different actigraphic modalities. J Neurosci Methods. 2001;105(2):185-91.
43. Acebo C, Sadeh A, Seifer R, Tzischinsky O, Wolfson AR, Hafer A, et al. Estimating sleep patterns with activity monitoring in children and adolescents: how many nights are necessary for reliable measures? Sleep. 1999;22(1):95-103.
44. Van Someren EJW, Swaab DF, Colenda CC, Cohen W, McCall WV, Rosenquist PB. Bright light therapy: improved sensitivity to its effects on rest-activity rhythms in Alzheimer patients by application of nonparametric methods. Chronobiol Int. 1999;16(4):505-18.
45. Wiggs L, Stores G. Severe sleep disturbance and daytime challenging behaviour in children with severe learning disabilities. J Intellect Disabil Res. 1996;40(6):518-28.
46. Héron B, Mikaeloff Y, Froissart R, Caridade G, Maire I, Caillaud C, et al. Incidence and natural history of mucopolysaccharidosis type III in France and comparison with United Kingdom and Greece. Am J Med Genet A. 2011;155A(1):58-68.
47. Cortesi F, Giannotti F, Ottaviano S. Sleep problems and daytime behaviour problems in childhood idiopathic epilepsy. Epilepsia. 1999;40(1):1557-65.
48. Guilleminault C, McCann CC, Querasalva M, Cetel M. Light treatment as treatment of dyschronosis in brain impaired children. Eur J Pediatr. 1993;152(9):754-9.
49. Palermo TM, Koren G, Blumer JL. Rational pharmacotherapy for childhood sleep disturbances: characteristics of an ideal hypnotic. Curr Ther Res. 2002;63(Suppl B):67-79.
50. Griggs RC, Batshaw M, Dunkle M, Gopal-Srivastava R, Kaye E, Krischer J, et al. Clinical research for rare diseases: opportunities, challenges and solutions. Mol Genet Metab. 2009;96(1):20-6.
51. Ancoli-Israel S, Cole R, Alessi C, Chambers M, Moorcroft W, Pollack CP. The role of actigraphy in the study of sleep and circadian rhythms. Sleep. 2003;26(3):342-92.
52. Laakso ML, Leinonen L, Lindblom N, Joutsiniemi SL, Kaski M. Wrist actigraphy in estimation of sleep and wake in intellectually disabled subjects with motor handicaps. Sleep Med. 2004;5(6):541-00.
53. Stephenson R. Circadian rhythms and sleep-related breathing disorders. Sleep Med. 2007;8(6):681-7.
54. Lin HY, Chen MR, Lin CC, Chen CP, Lin DS, Chuang CK, et al. Polysomnographic characteristics in patients with mucopolysaccharidoses. Pediatr Pulmonol. 2010;45(12):1205-12.
55. Bjorvatn B, Pallesen S. A practical approach to circadian rhythm sleep disorders. Sleep Med Rev. 2009;13(1):47-60.
56. Montgomery P, Stores G, Wiggs L. The relative efficacy of two brief treatments for sleep problems in young learning disabled (mentally retarded) children: a randomised controlled trial. Arch Dis Child. 2004;89(2):125-30.
57. 1-adrenergic antagonists and melatonin reset the clock and restore sleep in a circadian disorder, Smith-Magenis syndrome. J Med Genet. 2003;40(1):74-8.